Literature DB >> 16896829

Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock.

Y Heper1, E H Akalin, R Mistik, S Akgöz, O Töre, G Göral, B Oral, F Budak, S Helvaci.   

Abstract

The diagnostic value of procalcitonin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-10 levels in differentiating sepsis from severe sepsis and the prognostic value of these levels in predicting outcome were evaluated and compared in patients with community-acquired sepsis, severe sepsis, and septic shock in the first 72 h of admission to the hospital. Thirty-nine patients were included in the study. The severe sepsis and septic shock cases were combined in a single "severe sepsis" group, and all comparisons were made between the sepsis (n=21 patients) and the severe sepsis (n=18 patients) groups. Procalcitonin levels in the severe sepsis group were found to be significantly higher at all times of measurements within the first 72 h and were significantly higher at the 72nd hour in patients who died. Procalcitonin levels that remain elevated at the 72nd hour indicated a poor prognosis. C-reactive protein levels were not significantly different between the groups, nor were they indicative of prognosis. No significant differences in the levels of tumor necrosis factor-alpha were found between the sepsis and severe sepsis groups; however, levels were higher at the early stages (at admission and the 24th hour) in patients who died. Interleukin-10 levels were also higher in the severe sepsis group and significantly higher at all times of measurement in patients who died. When the diagnostic and prognostic values at admission were evaluated, procalcitonin and interleukin-10 levels were useful in discriminating between sepsis and severe sepsis, whereas tumor necrosis factor-alpha and interleukin-10 levels were useful in predicting which cases were likely to have a fatal outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896829     DOI: 10.1007/s10096-006-0168-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  32 in total

Review 1.  Procalcitonin: how a hormone became a marker and mediator of sepsis.

Authors:  B Müller; K L Becker
Journal:  Swiss Med Wkly       Date:  2001-10-20       Impact factor: 2.193

Review 2.  Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors.

Authors:  K L Becker; E S Nylén; J C White; B Müller; R H Snider
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

3.  Procalcitonin as a marker of severity in septic shock.

Authors:  J Schröder; K H Staubach; P Zabel; F Stüber; B Kremer
Journal:  Langenbecks Arch Surg       Date:  1999-02       Impact factor: 3.445

4.  Anti-inflammatory cytokine response and the development of multiple organ failure in severe sepsis.

Authors:  P Loisa; T Rinne; S Laine; M Hurme; S Kaukinen
Journal:  Acta Anaesthesiol Scand       Date:  2003-03       Impact factor: 2.105

5.  The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration.

Authors:  Guillaume Monneret; Marie-Emmanuelle Finck; Fabienne Venet; Anne-Lise Debard; Julien Bohé; Jacques Bienvenu; Alain Lepape
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

Review 6.  Procalcitonin as an early marker of infection in neonates and children.

Authors:  A M C van Rossum; R W Wulkan; A M Oudesluys-Murphy
Journal:  Lancet Infect Dis       Date:  2004-10       Impact factor: 25.071

7.  Early interleukin-10 treatment improves survival and enhances immune function only in males after hemorrhage and subsequent sepsis.

Authors:  Volker Kahlke; Christoph Dohm; Torge Mees; Kerstin Brötzmann; Stefan Schreiber; Jörg Schröder
Journal:  Shock       Date:  2002-07       Impact factor: 3.454

8.  Antioxidant amplifies antibiotic protection in the cecal ligation and puncture model of microbial sepsis through interleukin-10 production.

Authors:  Yashige Kotake; Danny R Moore; Angelica Vasquez-Walden; Tahereh Tabatabaie; Hong Sang
Journal:  Shock       Date:  2003-03       Impact factor: 3.454

9.  Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.

Authors:  Canan BalcI; Hülya Sungurtekin; Ercan Gürses; Ugur Sungurtekin; Bünyamin Kaptanoglu
Journal:  Crit Care       Date:  2002-10-30       Impact factor: 9.097

10.  Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

View more
  33 in total

1.  Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor.

Authors:  K Kofoed; J Eugen-Olsen; J Petersen; K Larsen; O Andersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-16       Impact factor: 3.267

2.  Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities.

Authors:  Bettina Schrag; Pascale Roux-Lombard; Deborah Schneiter; Paul Vaucher; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2011-07-07       Impact factor: 2.686

Review 3.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

4.  IL-33 Treatment Attenuates the Systemic Inflammation Reaction in Acinetobacter baumannii Pneumonia by Suppressing TLR4/NF-κB Signaling.

Authors:  Chunhong Peng; Jin Han; Xianwei Ye; Xiangyan Zhang
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

5.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

6.  The utility of serum procalcitonin in distinguishing systemic inflammatory response syndrome from infection after aneurysmal subarachnoid hemorrhage.

Authors:  Emir Festic; Jason Siegel; Matthew Stritt; William D Freeman
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

7.  ACG Clinical Guideline: Nutrition Therapy in the Adult Hospitalized Patient.

Authors:  Stephen A McClave; John K DiBaise; Gerard E Mullin; Robert G Martindale
Journal:  Am J Gastroenterol       Date:  2016-03-08       Impact factor: 10.864

Review 8.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

9.  IL-10-Induced miR-155 Targets SOCS1 To Enhance IgE-Mediated Mast Cell Function.

Authors:  Amina Abdul Qayum; Anuya Paranjape; Daniel Abebayehu; Elizabeth Motunrayo Kolawole; Tamara T Haque; Jamie Josephine Avila McLeod; Andrew J Spence; Heather L Caslin; Marcela T Taruselli; Alena P Chumanevich; Bianca Baker; Carole A Oskeritzian; John J Ryan
Journal:  J Immunol       Date:  2016-04-29       Impact factor: 5.422

10.  Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type.

Authors:  C Schoenbein; W-D Docke; K Wolk; G Belbe; C Hoflich; M Jung; G Grutz; W Sterry; H-D Volk; K Asadullah; R Sabat
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.